Objective To analyze the incidence rates and risk factors for bacteremia in patients undergoing hemodialysis (HD) and peritoneal dialysis (PD). Methods The records of 898 consecutive patients undergoing dialysis from January 2003 to December 2008 were reviewed retrospectively. Episodes of bacteremia were recorded. China Medical University (Taichung, Taiwan). Results The overall incidence rate of bacteremia was 7.63 per 100 patient-years in HD patients and 3.56 per 100 patient-years in PD patients and it was higher in HD patients each year from 2003 to 2008. S. aureus (27.53%) was the most common pathogen in HD patients, whereas Coagulase-negative Staphylococcus (21.3%) was the most common pathogen in PD patients. Vascular access infection was the most common etiology in HD patients, whereas peritonitis was the most common etiology in PD patients. Older age, shorter dialysis vintage, use of HD rather than PD, current smoker, use of a venous dialysis catheter, presence of diabetes mellitus, higher comorbidity score, and lower serum albumin were significant risk factors for bacteremia. Diabetes mellitus and lower serum albumin were significant risk factors for bacteremia-associated mortality. Conclusion Placement of a permanent access (fistula, graft, or PD catheter) prior to initiation of dialysis, smoking cessation, and better nutritional status (i.e. higher serum albumin) were associated with a reduced risk of bacteremia in dialysis patients. Higher serum albumin was also associated with a reduced bacteremiaassociated mortality.
Introduction
Infection is the second most common cause of mortality and is a major cause of morbidity in dialysis patients from the United States (1) . In addition, the annual mortality secondary to sepsis is approximately 100-to 300-fold higher in dialysis patients than in the general United States population (2) . A previous study of a single dialysis center in Taiwan reported that infection was the leading cause of mortality, and accounted for 49.6% of deaths (3) . Dialysis patients appear to be predisposed to infection due to alterations in primary host defense, advanced age, and the presence of comorbid conditions such as diabetes mellitus (DM), malnutrition, invasive dialysis procedures, disruption of skin and mucosa barriers, and susceptibility to nosocomial transmis-sion (4, 5) . Peritonitis, vascular access infection, bacteremia, pneumonia, and cellulitis are the most common types of infections in dialysis patients (1) .
A review of the US Renal Data System (USRDS) indicated that first year hospital admission rates for bacteremia were higher for hemodialysis (HD) patients than for peritoneal dialysis (PD) patients (1, 6) . However, a recent study of a single dialysis center in the US indicated that the overall infection rate in incident dialysis patients was similar for patients undergoing HD and PD, but that HD patients had a higher risk of bacteremia and PD patients had a higher risk of peritonitis (7) . Recent registry data from Australia and New Zealand indicated no significant difference in the incidence rate of sepsis mortality in HD and PD patients, but that PD patients had an increased hazard ratio of death from infection after six months of treatment (8) .
The presence of bacteremia in dialysis patients is associated with a poor prognosis (9, 10) and accounts for 75% of infection-associated deaths (2) . According to the USRDS Wave 2 study, bacteremia is significantly associated with an increase in subsequent death [hazard ratio (HR) 2.33], myocardial infarction (HR 1.64), heart failure (HR 1.64), peripheral vascular disease (HR 1.64), and stroke (HR 2.04) (9) . However, there are few studies of bacteremia in Asian dialysis patients.
The aims of the present study were to compare the incidence rate of bacteremia in HD and PD patients, to identify the responsible microorganisms, to assess the outcome of bacteremia, and to identify risk factors for bacteremia and bacteremia-related mortality at a single dialysis center in central Taiwan.
Materials and Methods

Study population
The records of patients undergoing HD or PD from January 2003 to December 2008 at the China Medical University Hospital, a tertiary medical center with 2000 beds in central Taiwan, were reviewed retrospectively. Dialysis modality was defined as PD or HD at the start of outpatient dialysis. Access in use was recorded at the start of outpatient dialysis. Exclusion criteria were: age less than 18 years, survival for less than 90 days after initiation of dialysis, and change in dialysis modality before January 2003. Patients were censored at death, transfer to another dialysis modality, discontinuation of dialysis, transplantation, and transfer to another dialysis center. Exit-site antibiotic prophylaxis was not used. Empiric antibiotic therapy such as vancomycin and/or cephalosporin was initiated for treatment of infection at the discretion of the attending physician. Antibiotic therapy was adjusted after the culture result was available. This study was approved by the Institutional Review Board of China Medical University Hospital.
Definition of bacteremia
Blood cultures were obtained when a patient had fever, chills, leukocytosis, or hypotension at the discretion of the attending physician. If only a single blood culture was positive for the skin contaminants such as coagulase-negative Staphylococcus, or aerobic gram-positive rods, and there was no clinical evidence of infection, the culture was regarded as contamination and not recorded. All other situations with at least one positive blood culture with clinical evidence of infection were considered as bacteremia episodes. All enrolled patients were admitted with bacteremia after outpatient dialysis. The incidence rate of bacteremia was calculated by dividing the total number of admissions with bacteremia by the total time at risk of the dialysis cohorts, and expressed as the number of bacteremia episodes per 100 patient-years. Time at risk was considered to begin at the initiation of outpatient dialysis. Bacteremia-associated mortality was defined as admission with bacteremia followed by in-hospital death. The infection focus was identified by clinical, bacteriological, and radiological investigations, and by agreement of blood cultures and cultures from specific body sites. Hospital-acquired bacteremia was defined as bacteremia occurring at two or more days after admission.
Data collection
Demographic data, comorbid conditions, initial dialysis access, and laboratory data were extracted from medical records. These data were collected at the start of dialysis for incident patients, on January 1, 2003 for prevalent patients, and during all bacteremia episodes. Laboratory data included hemoglobin, serum albumin, serum ferritin, Kt/V, and normalized protein nitrogen appearance (nPNA). Admission episodes with bacteremia and outcomes were also reviewed. The comorbidity score was calculated according to the method of Davies et al. (11) .
Statistical analysis
All values are expressed as means ± standard deviations. Variables were compared using the Chi-square test or Fisher's exact test for categorical variables. An independent t-test was used to compare continuous variables. Simple linear regression was used to evaluate trends. Poisson regression analysis was used to assess the impact of risk factors on the presence of bacteremia. As DM is a part of the comorbidity score, DM and comorbidity scores were analyzed separately. In addition, the initial access was correlated with dialysis modality, so these were also analyzed separately. A generalized estimating equation was used to evaluate the risk factors of in-hospital death. All analyses were performed using SAS statistical software (version 9.1 for Windows; SAS Institute, Inc., Cary, NC, USA). A pvalue of less than 0.05 was considered significant. 
Results
Demographic and clinical characteristics
We retrospectively reviewed the records of 898 consecutive dialysis patients (366 HD patients and 532 PD patients). Analysis of the demographic data indicated that HD patients were more likely to be older (58. 
Incidence rate
A total of 144 of the 898 dialysis patients (16.03%) had at least one episode of bacteremia ( Table 2 ). The follow-up periods were 1,599.0 and 1,938.2 patient-years for HD and PD, respectively. The overall incidence rate of bacteremia was 7.63 per 100 patient-years for HD patients and 3.56 per 100 patient-years for PD patients. There were 191 episodes of bacteremia, with 122 episodes in HD patients and 69 episodes in PD patients. DM patients had more episodes of bacteremia than non-DM patients (9.53 vs. 3.34 episodes per 100 patient-years, data not shown). A total of 57 of the bacteremia episodes (29.84%) were hospital-acquired (data not shown). Fig. 1 shows that the incidence rate of bacteremia from 2003 to 2008 was higher in HD patients than PD patients in all years. In HD patients, the incidence rate increased from 8.94 per 100 patient-years in 2003 to 10.5 per 100 patientyears in 2008, although this increase was not significant (p for trend = 0.289). In PD patients, there was no significant change in the incidence rate from 2003 to 2008. Table 2 shows that HD patients had more episodes of bacteremia due to vascular access than PD patients (44.26% vs. 5.80%, p<0.0001), and that PD patients had more episodes of bacteremia due to peritonitis than HD patients (37.68% vs. 0.82%, p<0.0001). Venous access infection was the most common source of bacteremia in HD patients (44.26%), and peritonitis was the most common source of bacteremia in PD patients (37.68%).
Source of bacteremia
Microorganisms causing bacteremia
A total of 272 microorganisms were cultured from the 191 episodes of bacteremia (Table 3) . A total of 42 episodes were due to infection by more than one microorganism. Gram-positive bacteria were more common than Gramnegative bacteria in all patients (50.73% vs. 41.91%), HD patients (49.43% vs. 42.13%), and PD patients (53.19% vs. 41.48%). Staphylococcus aureus was the most common species in all patients (23.53%), and in HD patients (27.53%), whereas Coagulase-negative Staphylococcus (21.27%) was the most common microorganism in PD patients.
In HD patients, the frequencies of Gram-positive and Gram-negative bacteria were relatively constant from 2003 to 2008 (Fig. 2A) . In PD patients, the frequency of Grampositive bacteria decreased and that of Gram-negative bacteria increased, although these trends were not significant (p for trend = 0.196) (Fig. 2B) .
Multivariate analysis of risk factors for bacteremia
Next, we performed multivariate Poisson regression analysis of all variables that had p-values of less than 0.3 in the initial univariate Poisson regression analysis ( 1.03-1.52) and the use of a venous dialysis catheter (tunneled cuffed or noncuffed catheter) (HR: 4.18, CI: 2.84-6.14) were also significant risk factors for bacteremia (data not shown).
Outcome of bacteremia and risk factors for inhospital mortality
For dialysis patients with bacteremia, the mortality rates were 30.89% for all patients, 24.59% for HD patients, and 42.02% for PD patients. Analysis of the risk factors for bacteremia-associated mortality indicated that DM (OR: 4.10, 95% CI: 1.21-13.92) and low serum albumin were significantly and independently associated with in-hospital mortality (Table 5) . 
Discussion
To the best of our knowledge, this study is the first to analyze the risk factors for bacteremia and bacteremiaassociated mortality in Asian dialysis patients. The present findings are consistent with previous reports of other populations which reported that use of a venous catheter, advanced age, DM, HD rather than PD, and low serum albumin were risk factors for bacteremia in dialysis patients (6, 9, 10, 12, 13) .
The present results indicate that the incidence rate of bacteremia was higher in HD patients than in PD patients in all years from 2003 to 2008. In addition, the incidence rate of bacteremia in HD patients increased from 8.94 per 100 patient-years in 2003 to 10.5 in 2008. We speculate that this may be due to the increased use of venous dialysis catheters during this time. A previous study by Foley et al. used hospitalization claim data to compare first-year septicemia hospitalization rates in annual incident dialysis patients and found that septicemia rates were higher in HD patients than in PD patients in each year from 1991 to 1999 (6) . In particular, the first year admission rates for septicemia in HD patients increased by 51% (11.6 per 100 patient-years in 1991 vs. 17.5 per 100 patient-years in 1999) whereas the first year admission rates for septicemia in PD patients increased by 40% (5.7 per 100 patient-years in 1991, 9.2 per 100 patient-years in 1997, 8.0 per 100 patient-years in 1999). We also found that shorter dialysis vintage and current smoking were risk factors for bacteremia. Previous research indicated that the survival rate of incident dialysis patients was lowest during the first year of treatment (1) . Patients with a shorter duration of dialysis may have unstable physical conditions and therefore be more susceptible to bacteremia. In addition, around 90% of initial blood access was a catheter in HD patients. The high rate of catheter use in the initial blood access might also contribute to the higher risk of bacteremia in patients with a shorter duration of hemodialysis. Smokers may have increased susceptibility to infection due to alterations in the respiratory tract and decreased immune response (14) . Previous research also indicated that smoking was a risk factor for bacteremia-related hospitalization and mortality (15) (16) (17) .
No previous studies have analyzed the organisms responsible for bacteremia in PD patients. In the present study, vascular access infection (44.26%) was the most common source of infection in HD patients, and peritonitis (37.68%) was the most common source of infection in PD patients. S. aureus was the most common microorganism in all patients (23.53%) and in HD patients (27.53%), whereas Coagulasenegative Staphylococcus (21.27%) was most common microorganism in PD patients. The mortality rate was 30.89%, 24.59%, and 42.02% for all patients, HD patients, and PD patients, respectively, similar to previous reports of other populations (12, (18) (19) (20) . For HD patients, previous reports demonstrated that S. aureus, coagulase-negative Staphylococcus, and Gram-negative rods were the major causative microorganisms of bacteremia, and vascular access was the major primary source of bacteremia (12, (18) (19) (20) . The mortality rate of bacteremia ranged from 6.3% to 33% in HD patients (18) (19) (20) .
Analysis of the local microbial distribution may help physicians in their choice of initial empiric antibiotics. We found a trend for an increase in the proportion of Gramnegative bacteria from 2003 to 2008 in PD patients. We speculate that this may have been due to the increased use of empiric antibiotics against Gram-positive microorganisms. Another important finding of the present study is that DM and lower serum albumin (an indicator of poor nutritional status) in HD and PD patients were significant risk factors for bacteremia-related mortality. This is the first study to report such results.
The main strengths of the present study are that we had a large sample size and performed long-term follow-ups. However, there were also several limitations of our study. First, we may have underestimated the incidence rate because we only recorded admission bacteremia episodes that occurred after outpatient dialysis. Second, we only used the initial dialysis access as a variable, but the access point may have changed during the five-year follow-up period. Third, we included patients with prevalent and incident dialysis, and this increased the heterogeneity of our population. Fourth, we may have overestimated the mortality rate due to bacteremia because some deaths may have been due to multiple factors.
In conclusion, bacteremia was a serious complication in our population of dialysis patients and it was associated with a high rate of mortality (30.89%). The incidence rate of bacteremia was higher in HD patients than in PD patients each year from 2003 to 2008. S. aureus (27.53%) was the most common pathogen in HD patients, whereas coagulasenegative Staphylococcus (21.3%) was most common pathogen in PD patients. Vascular access infection was the most common etiology in HD patients, whereas peritonitis was the most common etiology in PD patients. Older age, shorter dialysis vintage, HD rather than PD, current smoker, DM, higher comorbidity score, venous dialysis catheter, and lower serum albumin were significant independent risk factors for bacteremia. DM and lower serum albumin were significant independent risk factors for in-hospital mortality. Thus, we suggest placement of a permanent dialysis access (fistula, graft, or PD catheter) prior to the initiation of dialysis, quitting smoking, and improving nutritional status to reduce the risk of bacteremia. Improving the nutritional status can also reduce bacteremia-related mortality.
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